Droge- Groenenboom SRL
Droge- Groenenboom reported total assets of 472,588 € at the end of the 2024 financial year (annual accounts filed with the NBB on 29 Aug 2025).
The score of Droge- Groenenboom shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -73 % Total assets +116 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Droge- Groenenboom's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | −69,323 € | ||||
| Equity | 54,687 € | ||||
| Cash | 47,089 € | ||||
| EBITDA | −78,945 € | ||||
| Total assets | 472,588 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 17 Sep 2024
- Year ended 31 Dec 2022filed on 26 Sep 2023
- Year ended 31 Dec 2021filed on 08 Nov 2022
- Year ended 31 Dec 2020filed on 24 Nov 2021
Droge- Groenenboom's financial analysis
- Solvency11.6%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Droge- Groenenboom
Droge- Groenenboom's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0463.052.363
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 10 Apr 1998
- Registered office
- 2900 Schoten
- Latest accounts
- 2024 · filed on 29 Aug 2025
- Activity
- Activities of holding companies (NACE 64210)
Droge- Groenenboom (SRL) has been based in Schoten since 1998, active in: activities of holding companies. For 2024, it reports a net loss of 69,323 € and equity of 54,687 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Droge- Groenenboom
Companies in the same business, of comparable size and area, outside its group.
- Dr. Behaeghe General medical practice activities Sint-Martens-Latem · balance sheet 472,569 €
- Rentshop Antwerp · balance sheet 472,616 €
- Avenirose Uccle · balance sheet 460,495 €
- Raisani Retail sale of tobacco products Mouscron · balance sheet 472,387 €
- Compagnie des Cartes Activities of holding companies Etterbeek · balance sheet 472,366 €
- Docteur Bouillon Medical specialists activities Bernissart · balance sheet 472,285 €
- Dendergaard Development of building projects Deinze · balance sheet 472,125 €
- Dupont-Magritte Floor and wall covering Evere · balance sheet 473,184 €
Frequently asked questions about Droge- Groenenboom
What is the revenue of Droge- Groenenboom?
Droge- Groenenboom files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Droge- Groenenboom?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Droge- Groenenboom. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0463052363. Its company number (CBE) is 0463.052.363.
Where is the registered office of Droge- Groenenboom?
According to the CBE register, the registered office of Droge- Groenenboom is in 2900 Schoten.
What is the equity of Droge- Groenenboom?
At the close of the 2024 financial year, the equity of Droge- Groenenboom amounts to 54,687 €, a solvency of 11.6% of total assets.
Who manages Droge- Groenenboom?
The register lists 1 active mandates at Droge- Groenenboom. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Droge- Groenenboom
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →